| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |